Developer docs
API playgroundTry for free, no card

Search company profiles

I-Function

Full company profile

uuid00066ln

Namestring
I-Function
Legal namestring
i-Function, Inc.
Websiteurl
i-function.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

I-Function, Inc. is a privately held digital health company founded in 2016 and headquartered in Miami, Florida. The company develops cloud-based software tools for cognitive assessment and functional skills training, serving healthcare providers, managed care organizations, and clinical researchers. Its portfolio centers on two commercial products: LASSI-D, a 15-minute self-administered digital cognitive assessment that uses an AI avatar guide to detect early memory impairment associated with Alzheimer's disease; and FUNSAT, a 6-module interactive platform that evaluates and trains everyday functional skills such as online banking, medication management, and transportation. The platform is delivered via web browsers on computers and tablets, requires no specialized equipment, and is available in English and Spanish. The company has a research-driven product foundation, with tools validated across 4,000+ individuals in NIH-supported studies and an extensive peer-reviewed publication record in journals including Alzheimer's and Dementia, Journal of Alzheimer's Disease, and American Journal of Geriatric Psychiatry.

Short descriptiontext

I-Function is a Miami-based digital health company offering cloud-based cognitive assessment (LASSI-D) and functional skills training (FUNSAT) tools for healthcare providers, managed care plans, and clinical researchers focused on early Alzheimer's detection.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital cognitive assessment, functional skills training, Alzheimer's screening software, clinical assessment platform, healthcare SaaS tools
Industry3 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYEDAFAFAD
Intelligent Practice & Mastery Learning Platforms (Spaced Repetition, Skill Drills)
Education/Education Technology (EdTech) & Digital Learning/Education Analytics, Adaptive Learning & AI Tutoring Platforms
SECONDARYBPAEANAD
Digital Learning Content Development (eLearning, Labs, Simulations)
NAICS code2 codes
  • Educational Support Services61171
  • Educational Support Services611710
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Digital Cognitive Assessment Software
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Assessment Licensing - LASSI-D
TypeSubscription Recurring
Description

Organization purchases assessments at quantity-based pricing tiers. Standard tier for U.S. organizations up to 500 assessments; custom pricing for 500+ assessments or non-U.S. organizations.

i-function.com
2Training Platform Licensing - FUNSAT
TypeSubscription Recurring
Description

Subscription or usage-based licensing for access to functional skills training platform. Programs typically last 6-12 weeks with 1-2 weekly training sessions.

i-function.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Standard pricing for U.S. organizations purchasing up to 500 assessments
ModelSubscriptionBilling cadenceAnnual
Notes

Various pricing options based on purchasing quantity. Self-service purchase portal available for standard tier.

i-function.com
2Custom pricing for large organizations or non-U.S. purchasers
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Contact sales for 500+ assessments, non-U.S. organizations, or additional purchasing requirements. Sales team responds within 1-2 business days.

i-function.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1LASSI-D™
Description

A clinically validated 15-minute digital cognitive assessment for detecting early memory impairment and cognitive changes associated with Alzheimer's disease

i-function.com
+1 more record
Core offering1 text field

I-Function develops and sells cloud-based digital cognitive assessment and functional skills training software for the healthcare market. Its two principal commercial products are LASSI-D, a 15-minute self-administered digital cognitive assessment with AI avatar guidance for early detection of memory impairment associated with Alzheimer's disease, and FUNSAT, a 6-module interactive platform that evaluates and trains everyday functional skills such as online banking, medication management, and transportation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 98% of LASSI-D assessment users completed their self-administered cognitive assessment
+6 more records
Product overview1 text field

I-Function offers a platform of cognitive and functional skills assessment and training tools. The portfolio consists of two primary commercial products: LASSI-D™ (a brief self-administered digital cognitive assessment for early Alzheimer's detection) and FUNSAT™ (a functional skills assessment and training platform covering everyday technology-based tasks). Related research products include LASSI-L™ (paper-based version) and LASSI-BC™ (computerized research version). These products share NIH-supported validation research and target healthcare providers, managed care organizations, and clinical researchers focused on cognitive health.

Product and service4 records
1LASSI-D
CategoryDigital cognitive assessment software
Description

A clinically validated 15-minute self-administered digital cognitive assessment with AI avatar guidance that identifies early memory impairment and cognitive changes associated with Alzheimer's disease in people at increased risk, reporting approximately 90% specificity and 80% accuracy, automated scoring, care plan recommendations, and provider alerts. Sold to healthcare organizations for use with patients/members, available in English and Spanish, and delivered cloud-based on computers and tablets.

2FUNSAT
CategoryFunctional skills assessment and training software
Description

An interactive 6-module platform that evaluates and trains essential everyday functional skills including online banking, ATM banking, metro ticket kiosk, phone prescription refill, online pharmacy shopping, medication label comprehension, and medication organizer, with documented 50-200% increases in real-world skill use and 89-97% increases in medication management ability. Targeted at healthcare providers serving individuals who need to maintain or recover independence, including stroke survivors and people with cognitive impairment.

3LASSI-L
CategoryCognitive assessment (research edition)
Description

The original paper-based LASSI cognitive challenge test developed at the University of Miami Miller School of Medicine, designed to measure proactive semantic interference and detect early cognitive decline associated with Alzheimer's disease, used as the research foundation underlying LASSI-D.

4LASSI-BC
CategoryCognitive assessment (research edition)
Description

Initial research-focused computerized version of the LASSI-L test, providing standardized digital administration suitable for remote assessment with automated scoring.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founders Dr. Rosie Curiel, Dr. David Loewenstein, and Dr. Elizabeth Crocco are faculty members at University of Miami Miller School of Medicine. Research collaboration for development and validation of cognitive assessment tools. Company operates from Converge Miami (formerly UM Life Sciences and Technology Park).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research supported by NIH grants. Both LASSI-D and FUNSAT research validated in NIH-supported studies. Featured in 2024 NIH Alzheimer's and Related Dementias Research Progress Report.

3Center for Cognitive Neuroscience and Aging (CNSA)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliated research center at University of Miami where founders conduct research. Dr. David Loewenstein serves as Director of CNSA.

i-function.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BrainCheck offers a digital cognitive assessment and care planning platform used by health systems, physicians, and clinical trials. Directly comparable to LASSI-D in providing rapid, tablet-based cognitive screening with reimbursement-aligned workflows.

TypeDirect peer
Description

Cognivue has developed FDA-cleared digital cognitive assessment devices focused on early detection of memory impairment and dementia. Directly comparable to LASSI-D in the cognitive screening category, with stronger regulatory positioning but more specialized hardware requirements.

TypeDirect peer
Description

Cambridge Cognition provides digital cognitive testing solutions including the CANTAB battery, serving pharmaceutical clinical trials and healthcare providers. Comparable to I-Function in serving both clinical trial/research markets and enterprise healthcare with validated cognitive assessments.

TypeDirect peer
Description

Cogstate provides computerized cognitive testing primarily for clinical trials in Alzheimer's and other CNS indications. Directly comparable to I-Function's pharma/CRO segment and LASSI-L/LASSI-BC research variants.

TypeDirect peer
Description

Neurotrack offers digital cognitive health assessments and lifestyle interventions focused on memory and Alzheimer's risk. Directly comparable in targeting early cognitive decline detection with self-administered digital tools.

TypeEmerging player
Description

Linus Health combines digital cognitive assessments (including the DCTclock) with brain health analytics for early Alzheimer's detection. Comparable to LASSI-D as a digital-first cognitive assessment, with focus on primary care and health system integration.

TypeDirect peer
Description

Posit Science develops BrainHQ, a cognitive training platform with clinically validated exercises for memory, attention, and processing speed. Comparable to FUNSAT in delivering structured cognitive and functional skill training with documented clinical outcomes.

TypeEmerging player
Description

Altoida develops digital biomarkers and cognitive assessment tools using augmented reality and AI for early Alzheimer's prediction. Comparable to I-Function in targeting early cognitive impairment detection with novel digital approaches and pharma/CRO partnerships.

TypeEmerging player
Description

Savonix offers a mobile cognitive assessment platform providing brief, validated digital tests for memory and executive function. Comparable to LASSI-D as a self-administered digital cognitive assessment with research and clinical applications.

TypeOthers
Description

C2N Diagnostics develops PrecivityAD, a blood-based biomarker test for Alzheimer's disease detection. Mentioned in I-Function's own positioning as a more expensive alternative; serves the same early-detection clinical use case via a different modality (blood biomarker vs. digital assessment).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

I-Function

Digital Cognitive Assessment Softwarei-function.com

I-Function is a Miami-based digital health company offering cloud-based cognitive assessment (LASSI-D) and functional skills training (FUNSAT) tools for healthcare providers, managed care plans, and clinical researchers focused on early Alzheimer's detection.

What I-Function does

I-Function, Inc. is a privately held digital health company founded in 2016 and headquartered in Miami, Florida. The company develops cloud-based software tools for cognitive assessment and functional skills training, serving healthcare providers, managed care organizations, and clinical researchers. Its portfolio centers on two commercial products: LASSI-D, a 15-minute self-administered digital cognitive assessment that uses an AI avatar guide to detect early memory impairment associated with Alzheimer's disease; and FUNSAT, a 6-module interactive platform that evaluates and trains everyday functional skills such as online banking, medication management, and transportation. The platform is delivered via web browsers on computers and tablets, requires no specialized equipment, and is available in English and Spanish. The company has a research-driven product foundation, with tools validated across 4,000+ individuals in NIH-supported studies and an extensive peer-reviewed publication record in journals including Alzheimer's and Dementia, Journal of Alzheimer's Disease, and American Journal of Geriatric Psychiatry.

I-Function firmographics

Firmographics
Name
I-Function
Legal name
i-Function, Inc.
Website
https://i-function.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
I-Function is a Miami-based digital health company offering cloud-based cognitive assessment (LASSI-D) and functional skills training (FUNSAT) tools for healthcare providers, managed care plans, and clinical researchers focused on early Alzheimer's detection.
Ownership category
akta.pro rank

I-Function industry classification

Industry
Product category
Digital Cognitive Assessment Software
NAICS
Educational Support Services (61171), Educational Support Services (611710)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYEDAFAFAD
Intelligent Practice & Mastery Learning Platforms (Spaced Repetition, Skill Drills)
Education/Education Technology (EdTech) & Digital Learning/Education Analytics, Adaptive Learning & AI Tutoring Platforms
SECONDARYBPAEANAD
Digital Learning Content Development (eLearning, Labs, Simulations)

Keywords

  • Digital cognitive assessment
  • Functional skills training
  • Alzheimer's screening software
  • Clinical assessment platform
  • Healthcare SaaS tools

Where I-Function is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Offices1 record

Markets served

I-Function business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Assessment Licensing - LASSI-D: Organization purchases assessments at quantity-based pricing tiers. Standard tier for U.S. organizations up to 500 assessments; custom pricing for 500+ assessments or non-U.S. organizations.
  2. Training Platform Licensing - FUNSAT: Subscription or usage-based licensing for access to functional skills training platform. Programs typically last 6-12 weeks with 1-2 weekly training sessions.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualStandard pricing for U.S. organizations purchasing up to 500 assessments
SubscriptionMulti-year contractCustom pricing for large organizations or non-U.S. purchasers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

I-Function product offering

Product offering

Core offering

I-Function develops and sells cloud-based digital cognitive assessment and functional skills training software for the healthcare market. Its two principal commercial products are LASSI-D, a 15-minute self-administered digital cognitive assessment with AI avatar guidance for early detection of memory impairment associated with Alzheimer's disease, and FUNSAT, a 6-module interactive platform that evaluates and trains everyday functional skills such as online banking, medication management, and transportation.

Product overview

I-Function offers a platform of cognitive and functional skills assessment and training tools. The portfolio consists of two primary commercial products: LASSI-D™ (a brief self-administered digital cognitive assessment for early Alzheimer's detection) and FUNSAT™ (a functional skills assessment and training platform covering everyday technology-based tasks). Related research products include LASSI-L™ (paper-based version) and LASSI-BC™ (computerized research version). These products share NIH-supported validation research and target healthcare providers, managed care organizations, and clinical researchers focused on cognitive health.

Differentiator

Problem solved

Functional benefit

Brands

  • LASSI-D™: A clinically validated 15-minute digital cognitive assessment for detecting early memory impairment and cognitive changes associated with Alzheimer's disease
  • FUNSAT™

Products and services

  • LASSI-D A clinically validated 15-minute self-administered digital cognitive assessment with AI avatar guidance that identifies early memory impairment and cognitive changes associated with Alzheimer's disease in people at increased risk, reporting approximately 90% specificity and 80% accuracy, automated scoring, care plan recommendations, and provider alerts. Sold to healthcare organizations for use with patients/members, available in English and Spanish, and delivered cloud-based on computers and tablets.
  • FUNSAT An interactive 6-module platform that evaluates and trains essential everyday functional skills including online banking, ATM banking, metro ticket kiosk, phone prescription refill, online pharmacy shopping, medication label comprehension, and medication organizer, with documented 50-200% increases in real-world skill use and 89-97% increases in medication management ability. Targeted at healthcare providers serving individuals who need to maintain or recover independence, including stroke survivors and people with cognitive impairment.
  • LASSI-L The original paper-based LASSI cognitive challenge test developed at the University of Miami Miller School of Medicine, designed to measure proactive semantic interference and detect early cognitive decline associated with Alzheimer's disease, used as the research foundation underlying LASSI-D.
  • LASSI-BC Initial research-focused computerized version of the LASSI-L test, providing standardized digital administration suitable for remote assessment with automated scoring.

Quantifiable outcome

  • 98% of LASSI-D assessment users completed their self-administered cognitive assessment
  • +6 more outcomes

Companies that use I-Function

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles4 records

I-Function technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

I-Function partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • University of Miami Miller School of MedicinecoreStrategic or Co-development PartnerFounders Dr. Rosie Curiel, Dr. David Loewenstein, and Dr. Elizabeth Crocco are faculty members at University of Miami Miller School of Medicine. Research collaboration for development and validation of cognitive assessment tools. Company operates from Converge Miami (formerly UM Life Sciences and Technology Park).
  • NIH (National Institutes of Health)coreStrategic or Co-development PartnerResearch supported by NIH grants. Both LASSI-D and FUNSAT research validated in NIH-supported studies. Featured in 2024 NIH Alzheimer's and Related Dementias Research Progress Report.
  • Center for Cognitive Neuroscience and Aging (CNSA)coreStrategic or Co-development PartnerAffiliated research center at University of Miami where founders conduct research. Dr. David Loewenstein serves as Director of CNSA.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

I-Function competitors and assessment

Company assessment

Direct peers

  • BrainCheck: BrainCheck offers a digital cognitive assessment and care planning platform used by health systems, physicians, and clinical trials. Directly comparable to LASSI-D in providing rapid, tablet-based cognitive screening with reimbursement-aligned workflows.
  • Cognivue: Cognivue has developed FDA-cleared digital cognitive assessment devices focused on early detection of memory impairment and dementia. Directly comparable to LASSI-D in the cognitive screening category, with stronger regulatory positioning but more specialized hardware requirements.
  • Cambridge Cognition: Cambridge Cognition provides digital cognitive testing solutions including the CANTAB battery, serving pharmaceutical clinical trials and healthcare providers. Comparable to I-Function in serving both clinical trial/research markets and enterprise healthcare with validated cognitive assessments.
  • Cogstate: Cogstate provides computerized cognitive testing primarily for clinical trials in Alzheimer's and other CNS indications. Directly comparable to I-Function's pharma/CRO segment and LASSI-L/LASSI-BC research variants.
  • Neurotrack: Neurotrack offers digital cognitive health assessments and lifestyle interventions focused on memory and Alzheimer's risk. Directly comparable in targeting early cognitive decline detection with self-administered digital tools.
  • Posit Science (BrainHQ): Posit Science develops BrainHQ, a cognitive training platform with clinically validated exercises for memory, attention, and processing speed. Comparable to FUNSAT in delivering structured cognitive and functional skill training with documented clinical outcomes.

Emerging players

  • Linus Health: Linus Health combines digital cognitive assessments (including the DCTclock) with brain health analytics for early Alzheimer's detection. Comparable to LASSI-D as a digital-first cognitive assessment, with focus on primary care and health system integration.
  • Altoida: Altoida develops digital biomarkers and cognitive assessment tools using augmented reality and AI for early Alzheimer's prediction. Comparable to I-Function in targeting early cognitive impairment detection with novel digital approaches and pharma/CRO partnerships.
  • Savonix: Savonix offers a mobile cognitive assessment platform providing brief, validated digital tests for memory and executive function. Comparable to LASSI-D as a self-administered digital cognitive assessment with research and clinical applications.

Others

  • C2N Diagnostics: C2N Diagnostics develops PrecivityAD, a blood-based biomarker test for Alzheimer's disease detection. Mentioned in I-Function's own positioning as a more expensive alternative; serves the same early-detection clinical use case via a different modality (blood biomarker vs. digital assessment).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

I-Function financial estimates

Financial estimate

Revenue estimate

Valuation estimate

I-Function leadership team

Management profile

Number of profiles

Profiles3 records

I-Function funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

I-Function M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about I-Function

What does I-Function do?

I-Function develops and sells cloud-based digital cognitive assessment and functional skills training software for the healthcare market. Its two principal commercial products are LASSI-D, a 15-minute self-administered digital cognitive assessment with AI avatar guidance for early detection of memory impairment associated with Alzheimer's disease, and FUNSAT, a 6-module interactive platform that evaluates and trains everyday functional skills such as online banking, medication management, and transportation.

Is I-Function a public or private company?

I-Function is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was I-Function founded?

I-Function was founded in 2016. It employs 1 to 10 people.

Where is I-Function based?

I-Function is headquartered in Miami, United States, in the North America region.

How does I-Function make money?

Two revenue lines are on record. Assessment Licensing - LASSI-D is the primary driver. The others are training Platform Licensing - FUNSAT.

Who are I-Function's main competitors?

Direct peers on record are BrainCheck, Cognivue, Cambridge Cognition, Cogstate, Neurotrack and Posit Science (BrainHQ). Emerging players are Linus Health, Altoida and Savonix. C2N Diagnostics is listed as an others.

Does I-Function have an API?

No public API is recorded for I-Function.

What industry is I-Function in?

I-Function's product category is Digital Cognitive Assessment Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of EDAFAFAD, Intelligent Practice & Mastery Learning Platforms (Spaced Repetition, Skill Drills). Its NAICS code is 61171 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals